|
OMIM |
Link |
Information gain |
01 |
|
adrenal unresponsiveness to acth
|
[NCBI]
|
0.00277021
|
|
|
NPPA
|
[NCBI]
|
0.000451984
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
0.000439703
|
|
|
GRA
|
[NCBI]
|
0.000380023
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
0.000354043
|
|
|
AVP
|
[NCBI]
|
0.000353475
|
|
|
PHA1
|
[NCBI]
|
0.000345741
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
0.000341942
|
|
|
PHA2
|
[NCBI]
|
0.000209859
|
|
|
APS1
|
[NCBI]
|
0.00014076
|
|
|
por deficiency
|
[NCBI]
|
0.000103266
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
9.21595e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
8.58334e-05
|
|
|
AHC
|
[NCBI]
|
8.09058e-05
|
|
|
CYP11B2
|
[NCBI]
|
6.98285e-05
|
|
|
hypertension, essential
|
[NCBI]
|
6.42809e-05
|
|
|
CPI
|
[NCBI]
|
5.46825e-05
|
|
|
PNMT
|
[NCBI]
|
3.30887e-05
|
|
|
ALD
|
[NCBI]
|
2.85105e-05
|
|
|
GABRD
|
[NCBI]
|
2.40927e-05
|
|
|
POR
|
[NCBI]
|
2.35586e-05
|
|
|
GABRA1
|
[NCBI]
|
2.2219e-05
|
|
|
CRHR1
|
[NCBI]
|
1.97447e-05
|
|
|
CRH
|
[NCBI]
|
1.95794e-05
|
|
|
GCCR
|
[NCBI]
|
1.3498e-05
|
|
|
SOD2
|
[NCBI]
|
1.21708e-05
|
|
|
MDD
|
[NCBI]
|
1.15087e-05
|
|
|
CALCRL
|
[NCBI]
|
1.04566e-05
|
|
|
SPP1
|
[NCBI]
|
7.95144e-06
|
|
|
SERPINA6
|
[NCBI]
|
6.28048e-06
|
|
|
STAR
|
[NCBI]
|
5.49188e-06
|
|
|
VEGF
|
[NCBI]
|
4.96219e-06
|
|
|
CTGF
|
[NCBI]
|
3.44867e-06
|
|
|
NPY
|
[NCBI]
|
3.35017e-06
|
|
|
POMC
|
[NCBI]
|
1.8752e-06
|
|
|
SLC6A3
|
[NCBI]
|
1.84489e-06
|
|
|
PPARA
|
[NCBI]
|
1.35343e-06
|
|
|
GNRH1
|
[NCBI]
|
1.26648e-06
|
|
|
CCK
|
[NCBI]
|
7.72827e-07
|
|
|
G6PD
|
[NCBI]
|
6.85206e-07
|
|
|
PTH
|
[NCBI]
|
3.61942e-07
|
|
|
GFAP
|
[NCBI]
|
3.45323e-07
|
|
|
MPO
|
[NCBI]
|
2.12193e-07
|
|
|
TH
|
[NCBI]
|
9.10853e-08
|
|
|
PRL
|
[NCBI]
|
3.03819e-08
|
|
|
MBP
|
[NCBI]
|
2.88898e-08
|
|
|
APOE
|
[NCBI]
|
2.84376e-08
|
|
|
EGF
|
[NCBI]
|
8.67496e-09
|
|
|
CAT
|
[NCBI]
|
1.90971e-09
|
|
|
LPL
|
[NCBI]
|
4.05257e-10
|
|